Background. Obstructive sleep apnea syndrome (OSAS) is a common disorder that affects 2% to 9% of the population. Health care policy makers have noted increased referrals for sleep studies.Objective. In this article, the authors conduct a cost-effectiveness analysis to determine the optimal technology for the diagnosis of OSAS using polysomnography (PSG) or partial sleep monitoring (PSM).Design. The target population was a hypothetical cohort of patients suspected of having OSAS. A 2-level decision tree was formulated that reflects all possible steps of OSAS diagnosis and therapy. The method represents a comprehensive strategy to determine which of the 2 systems—PSG or PSM—has cost advantages. The financial and operational aspects of OSAS diagnosis and therapy were analyzed. A sensitivity analysis was performed over all uncertain parameters (i.e., diagnostic agreement, data loss, and referral to therapy).Results. Unattended at-home sleep monitoring was the most expensive method. The combination of 1:2 PSG and attended PSM strategy was the optimal strategy with respect to financing and operations. Compared to the PSG-only strategy, this combination may lead to a 10% reduction of the annual expenditure.Conclusion. This study provides proof of concept (under a wide range of sensitivity assumptions) that the cost of sleep study techniques can be modeled. It rejects the assumption that at-home portable sleep monitoring is cost advantageous. The combination of PSG and attended PSM OSAS is the most cost-effective approach to sleep evaluation.
Whittle AT, Finch SP, Mortimore IL, MacKay TW, Douglas NJ. Use of home sleep studies for diagnosis of sleep apnoea/hypopnoea syndrome. Thorax. 1997;52:1068-1073.
2.
Kryger MH, Roos L, Delaive K, Wald R, Horrocks J.Utilization of health care services in patients with severe obstructive sleep apnea. Sleep. 1996;19(suppl):S111-S116.
3.
Peker Y, Hedner J, Johansson A, Bende M.Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep. 1997;20:645-653.
4.
Fischer J, Raschke F.Economic and medical significance of sleep-related breathing disorders. Respiration. 1997;64:39-44.
5.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S.The occurrence of sleep-disordered breathing among middle-age adults. N Engl J Med. 1993;238:1230-1235.
6.
Stradling LR. Obstructive sleep apnea: definitions, epidemiology, and natural history. Thorax. 1995;50:683-689.
7.
Lugaresi E, Cirignotta F, Gerardi R, Montagna P.Snoring and sleep apnea: natural history of heavy snorers disease. In: Guilleminault C, Partinen M, editors. Obstructive sleep apnea syndrome: clinical research and treatment. New York, NY: Raven Press; 1990. p. 25-36.
8.
American Thoracic Society. Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis. 1989;139:559-568.
American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med. 1994;150:1738-1745.
11.
American Sleep Disorders Association Review. The indications for polysomnography and related procedures. Sleep. 1997;20:423-486.
12.
White DP, Gibb TJ, Wall JM, Westbrook PR. Assessment of accuracy and analysis time of a novel device to monitor sleep and breathing in the home. Sleep. 1995;18:115-126.
13.
Zucconi M, Ferini-Strambi L, Castronov V, Oldani A, Smirin S.An unattended device for sleep-related breathing disorders: validation study in suspected obstructive sleep apnoea syndrome. Eur Respir J. 1996;9:1251-1256.
14.
Ferber R, Millman R, Coppola M, et al.Portable recording in the assessment of obstructive sleep apnea: ASDA standards of practice. Sleep. 1994;17:378-392.
15.
Drummond MF, O’Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed.Oxford, UK: Oxford University Press; 1998.
Gyulay S, Gould D, Sawyir B, Pond D, Mant A, Saunds N.Evaluation of microprocessor-based portable home monitoring system to measure breathing during sleep. Sleep. 1987;10:130-142.
21.
Ancoli-Israel S, Kripke DF, Mason W, Messin S.Comparisons of home sleep recording and polysomnography in older adults with sleep disorders. Sleep. 1981;4:283-291.
22.
Svanborg E, Larsson H, Carlsson-Nordlander B, Pirskanen R.A limited diagnostic investigation for sleep apnea syndrome: oximetry and static charge sensitive bed. Chest. 1990;98:1341-1345.
23.
Emesellem HA, Corson WA, Rappaport BA, Hackett S, Smith GL, Haufeld JN. Verification of sleep apnea using a portable sleep apnea screening device. South Med J. 1990;83:748-752.
24.
Oee WC, Eiken T, Pergram V, Jones R, Rundell OH. A laboratory validation study of a portable system for remote recording of sleep-related respiratory disorders. Chest. 1994;105:160-162.
25.
Herman J, Penzel T.Portable monitoring of sleep and breathing. In: Sanders NA, Sullivan CE, editors. Sleep and breathing. 2nd ed.New York, NY: Dekker; 1994.
26.
Redline S, Tosteson R, Boucher MA, Millman RP. Measurement of sleep-related breathing disturbances in epidemiological studies: assessment of the validity and reproducibility of a portable monitoring device. Chest. 1991;100:1281-1286.
27.
Ferber R.Sleeplessness, night awakening, and night crying in the infant and toddler. Pediatr Rev. 1987;9:69-82.
28.
Peter JH. Economic aspects of sleep medicine. Wein Med Wochenschr. 1996;146:395-401.
29.
Chervin RD, Murman DL, Malow BA, Totten V.Cost-utility of three approaches to the diagnosis of sleep apnea: polysomnography, home testing, and empirical therapy. Ann Intern Med. 1999;130:496-505.
30.
Pack AI, Gurubhagavatula I.Economic implications of the diagnosis of obstructive sleep apnea. Ann Intern Med. 1999;130:533-534.
31.
American Sleep Disorders Association Report. Practice parameters of the indications for polysomnography and related procedures. Sleep. 1997;20:406-422.
32.
Viner S, Szalai JP, Hofstein V.Are history and physical examination a good screening test for sleep apnea?Ann Intern Med. 1991;115:359-365.
